ReviewClinical pharmacology and therapeutics2026
Model-Informed Drug Development for Daprodustat Supports the Design of Individualized Dosing Regimens in Chronic Kidney Disease Patients With Anemia.
Kelly M Mahar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.